Table III.
Association between the expression levels of miR-190b and clinicopathological characteristics in patients with pancreatic cancer.
| Characteristics | n | Median (quartiles) of miR-190b expression | P-value |
|---|---|---|---|
| Sex | 0.57 | ||
| Male | 25 | 0.19 (0.09-0.38) | |
| Female | 25 | 0.21 (0.11-0.48) | |
| Age (years) | 0.53 | ||
| ≥60 | 31 | 0.21 (0.10-0.42) | |
| <60 | 19 | 0.18 (0.11-0.38) | |
| pT stage | 0.000a | ||
| T1 | 8 | 0.52 (0.39-0.67) | |
| T2 | 25 | 0.24 (0.18-0.41) | |
| T3 | 16 | 0.10 (0.06-0.13) | |
| T4 | 1 | 0.03 | |
| pN stage | 0.018a | ||
| N0 | 34 | 0.21 (0.12-0.52) | |
| N1 | 12 | 0.20 (0.12-0.38) | |
| N2 | 4 | 0.06 (0.03-0.10) | |
| 8th AJCC stage | 0.000a | ||
| IA | 6 | 0.58 (0.48-0.71) | |
| IB | 17 | 0.24 (0.18-0.49) | |
| IIA | 11 | 0.10 (0.06-0.15) | |
| IIB | 12 | 0.20 (0.12-0.38) | |
| III | 3 | 0.08 (0.03-0.10) | |
| IV | 1 | 0.03 | |
| Obstructive jaundice | 0.49 | ||
| Negative | 29 | 0.19 (0.10-0.37) | |
| Positive | 21 | 0.24 (0.11-0.56) | |
| Tumor site | 0.81 | ||
| Pancreatic body | 7 | 0.19 (0.05-0.53) | |
| Pancreatic body and tail | 14 | 0.19 (0.10-0.28) | |
| Pancreatic head | 29 | 0.21 (0.11-0.46) |
a
Statistically significant association AJCC, American Joint Committee on Cancer; miR, microRNA.